Latest PSNC News

Visit PSNC website
  • If an emergency situation means a pharmacy needs to close for a short period, there are actions a contractor needs to undertake to ensure patients are able to access their prescriptions and that the contractor’s business can resume easily and effectively once the emergency has passed. The following PSNC Briefing provides guidance on planning which […]
  • NHS England has informed PSNC that there is currently (5th August 2022) an IT system outage with the Adastra system, used by many NHS 111 service providers across England. This is affecting services that receive electronic referrals and bookings from NHS 111, including referrals to the Community Pharmacist Consultation Service (CPCS). Each region of England […]
  • Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 28 new products entered the list of ‘Drugs for which Discount is Not Deducted’ (DND) in Part II of the Drug Tariff from 1 August 2022: For a list of all the monthly […]
  • PSNC entered negotiations on the Community Pharmacy Contractual Framework (CPCF) for 2022/23 with NHS England (NHSE) and the Department of Health and Social Care (DHSC) in late spring, and we know that contractors and LPCs are rightly anxious to know the outcomes of those discussions. We and officials from DHSC and NHSE agreed to an […]
  • National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Mexiletine hydrochloride 50mg, 100mg and 200 mg Hard Capsules, Clinigen Healthcare Ltd, due to a potential for underdosing and/or overdosing National Patient Safety Alert Reference Number: NatPSA/2022/007/MHRA Date issued: 4th August 2022 Clinigen Healthcare Ltd is initiating a recall of three batches of Mexiletine […]
  • Department of Health and Social Care (DHSC) has issued a medicine supply notification for Aripiprazole 10mg tablets. MSN/2022/066 Tier 2 – medium impact Date of issue 3rd August 2022 Aripiprazole 10mg tablets are in limited supply until late August 2022. Alternative strengths and formulations of aripiprazole remain available, but no individual product can support a […]